18
Aug 2020
New Alzheimer’s drug could be approved for use in US by March 2021
An experimental Alzheimer’s drug will get a fast track review for approval from the US Food and Drug Administration (FDA), according to the treatment’s makers. If approved, the drug aducanumab would be the first treatment designed to delay progression of the disease. In studies undertaken last year, the highly-anticipated drug improved brain function for patients…